Next Article in Journal
Advanced Paternal Age Does Not Affect Medically-Relevant Obstetrical and Perinatal Outcomes following IVF or ICSI in Humans with Donated Oocytes
Previous Article in Journal
Parents Rate Problematic Video Streaming in Adolescents: Conceptualization and External Assessment of a New Clinical Phenomenon Based on the ICD-11 Criteria of Gaming Disorder
Previous Article in Special Issue
The Use of Matriderm® for Scalp Full-Thickness Defects Reconstruction: A Case Series
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Diagnosis and Treatment in Unilateral Condylar Hyperplasia

1
Department of Oral and Maxillofacial Surgery, Hospital Clínico Regional Guillermo Grant Benavente, Concepción 4070038, Chile
2
Division of Oral and Maxillofacial Surgery, University of Concepción, Concepción 4030000, Chile
3
Center for Research in Epidemiology, Economics and Oral Public Health (CIEESPO), Faculty of Dentistry, Universidad de La Frontera, Temuco 4780000, Chile
4
Faculty of Dentistry, Universidad San Sebastián, Puerto Montt 5480000, Chile
5
PhD Program in Morphological Sciences, Universidad de La Frontera, Temuco 4780000, Chile
6
Faculty of Health Sciences, Universidad Autonoma de Chile, Temuco 4780000, Chile
7
Department of Oral and Maxillofacial Surgery, Federal University of Juiz de Fora, Juiz de Fora 36000-000, Brazil
8
Division of Oral, Facial and Maxillofacial Surgery, Universidad de La Frontera, Temuco 4780000, Chile
9
Center of Excellence in Morphological and Surgical Studies (CEMyQ), Universidad de La Frontera, Temuco 4780000, Chile
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2023, 12(3), 1017; https://doi.org/10.3390/jcm12031017
Submission received: 2 October 2022 / Revised: 31 October 2022 / Accepted: 14 November 2022 / Published: 28 January 2023
(This article belongs to the Special Issue New Frontiers in Facial Surgery)

Abstract

:
Unilateral condylar hyperplasia (UCH) is an uncommon disease involving progressive facial asymmetry. The aim of this research was to perform an analysis of the diagnosis and treatment of patients with UCH in a clinical series. An observational retrospective study was performed on subjects with progressive facial asymmetry in the lower third of the face; all the subjects were under treatment with condylectomy and orthodontics to improve occlusion and face balance. Variables such as age, sex, clinical type, SPECT (single photon emission computed tomography) intensity and a requirement for secondary surgery were included; the Shapiro Wilk test was performed to analyze the normality of the data and nonparametric analysis and the Kruskal-Wallis or Mann-Whitney tests were used to assess the association between the SPECT difference and the variables, where 2-tailed p values < 0.05 were considered to be statistically significant. Forty-nine patients between 10 and 45 y.o. (average age: 19.1 ± 7.4 y.o.) were included in the study. There were 41 female (83.6%) and 8 male (16.4%) subjects. The SPECT analysis comparing the right and left condyles with more than 10% in caption of the isotope was present in 46 subjects; the results obtained using SPECT were not statistically related to the age or sex of the sample (p = 0.277). The patients were classified into clinical types I, II and III, and no correlations could be confirmed between the clinical type and other variables. High condylectomy was conducted on all patients, among which 14 patients underwent a secondary surgery for orthognathic or cosmetic treatment, and was not related to the initial variables used in diagnosis (p = 0.98); interestingly, the second surgical treatment was more present in the clinical type I and in subjects under 16 years old with no statistical differences. Clinical analysis, medical records, 3D imaging and SPECT should be used as a complementary analysis in assessing the diagnosis of UCH and progressive facial asymmetry.

1. Introduction

Unilateral condylar hyperplasia (UCH) is a rare disease involving the middle and lower third of the face; UCH was described by Adams in 1936 and diagnosis remains controversial, although some protocols have been reported for the diagnosis of progressive facial asymmetry [1]. Clinical photographs, 2D or 3D images, SPECT and dental casts have been proposed as diagnostic routes [2,3] (Figure 1).
Some reports have shown that single photon emission computed tomography (SPECT) can be effectively used in diagnosis to identify abnormal growth in a mandibular condyle [4]; however, other reports have shown poor specificity and sensitivity of SPECT as a diagnostic test, with 30% to 60% concordance [5].
In terms of clinical classification, UCH was first proposed by Obwegesser and Makek [6] and later by Wolford et al. [7], showing characteristics of the disease as a type of deformity, age and clinical considerations about treatment (Figure 2 and Figure 3).
Age has been considered an important variable to understand the evolution of facial asymmetry; in this sense, early treatment could resolve facial asymmetry and dental occlusion in better conditions than later treatment [8] (Figure 3).
SPECT and clinical characteristics are included in the diagnosis of UCH (Table 1); however, those variables have not been clearly correlated with the diagnosis and progression of facial asymmetry. The aim of this research was to perform an analysis of the diagnosis and treatment of patients with UCH in a clinical series.

2. Material and Methods

Observational retrospective research in consecutive patients was designed. Included in this research were 49 male and female subjects, consulted for progressive facial asymmetry, with an age between 10 and 45 years old. Patients with a history of facial trauma, congenital facial deformity or treatment of benign or malignant maxillofacial tumors were excluded. All patients approved the study protocol and signed an informed consent form; this study was conducted in accordance with the guidelines of the Helsinki Declaration and approved by the Ethical Committee for Research with the Protocol UFJF-IRB 2.148.583.
All the subjects were submitted to clinical analysis. The progression of the facial asymmetry in the last year was confirmed subjectively by patients and family; subjects were grouped by facial asymmetry related to clinical type and dental occlusion [6]. Subsequently, a CBCT (MORITA, Veraviewepocs 3D R100, resolution images of 125 μm voxel, field of view (FOV or area exposures) Ø 40 × H 80 mm) of the temporomandibular joint was obtained, and SPECT (Sophy DST-Xli model, open-gantry SPECT gamma camera, SMV, France) was performed to compare the right and left sides of the face using the OSEM 3D (Ordered Subsets Expectation Maximization; Siemens Medical Solutions, Erlangen, Germany) reconstruction method with 3D collimator beam modeling and optional attenuation. SPECT, as a quantitative variable, was used to serve as an independent variable.
The data included in the analysis were sex, age, clinical type, surgery and a SPECT report. The clinical type was classified as type I, type II and type III [6]. Age was analyzed to find differences between the younger and older groups; the SPECT analysis was used to determine differences between the left and right condyles related to the caption of the radioisotope (Table 2).
After diagnosis, all the patients were treated using condylectomy of the hyperplastic condyle and orthodontics; orthognathic or cosmetic surgery was performed a second time, when necessary, to achieve facial symmetry, dental and facial balance and normal function.
All the samples with a UCH diagnosis were included in the statistical analysis. The Shapiro Wilk test was performed to analyze the normality of the data. Given the clearly skewed distribution of the SPECT difference, we decided to use nonparametric analysis, and Kruskal-Wallis or Mann-Whitney tests were used to assess the association between the SPECT difference and covariables. Two-tailed p values <0.05 were considered statistically significant. The data analyses were performed using Stata 15 (Stata Corp, College Station, TX, USA).

3. Results

Forty-one female (83.6%) and 8 male subjects (16.4%) were included with an age between 10 to 45 years old (19.1 ± 7.4 years old). The left side was affected in 27 cases (55.2%) and the right side was affected in 22 cases (44.8%).
In all subjects, the UCH and progressive asymmetry in the lower third of the face was confirmed; SPECT images obtained using 99cTc showed differences between the right and left sides, showing 11 patients with 10% or less in difference. Specifically, the difference between the left and right condyles was 6% in 3 cases, 10% in 8 cases and between 12% and 48% in the remaining 36 cases (Table 1). Sex was not related to the SPECT results and the intensity of the SPECT was not associated to the female or male (p = 0.174).
The clinical types were classified as type I for 22 subjects (44.9%), type II for 10 cases (20.4%) and type III for 17 cases (34.7%) and was not correlated with the SPECT results (p = 0.058).
The average age was 16.8 (3.5) for clinical type I patients, 22.7 (11.2) for clinical type II patients and 20.6 (5.6) for clinical type III patients; although a lower average age and a low standard deviation were found for clinical type I group when compared to type II and type III, no statistical relation was observed between age and clinical type (p = 0.354).
High condylectomy of the mandibular condyle and orthodontics were performed in all patients to treat UCH. A second surgical time with orthognathic surgery or cosmetic surgery to treat residual facial asymmetry was performed on 14 subjects (28.5%) with no relations to any variable revised in the initial diagnosis as SPECT results, the age in the first surgery or any other variable (p = 0.98). In the clinical type I, only one subject (4.5%) was involved in a secondary surgery (Table 2); in the clinical type II, 5 subjects (50%) were included in a secondary surgery (Table 3) and in the clinical type III, 8 subjects (36.7%) were treated with secondary surgery to get better function or esthetic conditions (Table 4). No statistical differences were observed (p = 0.443) between groups.
Interestingly, subjects with diagnosis and treatment realized between 10 and 16 years of age had only 2 subjects (9.5%) require a second surgical procedure (Table 5 and Table 6); after 17 years of age, the unilateral high mandibular condylotomy was followed by a second surgical treatment in 12 subjects (42.8%). Even with this difference, no statistical differences were observed in age related to second surgery requirements (p = 0.189).

4. Discussion

Unilateral condylar hyperplasia (UCH) is a rare disease related to the lower third of the face, leading to facial asymmetry [9]. The reason for consultation is usually progressive facial asymmetry and changes in dental occlusion [10]. Incidence of this pathology is difficult to obtain because of the uncommon nature of the disease.
Female predominance in UCH was reported previously in some articles [1,10] showing a clear trend. In this research, no statistical differences were observed; however, 83.6% of subjects were female and only 16.5% were male. It has been discussed that the hormonal conditions in the female could be involved in the development of UCH; however, there is no consensus in this field [3,4,5]. Most likely, a statistical difference between male and female could be observed in a larger sample.
Clinical presentation usually shows chin deviation and asymmetric class III dental occlusion because the nonaffected condyle grows normally or close to normally and the affected side grows abnormally large [3,7,10], moving the neck, ramus and body of the mandible in a forward and contralateral direction, resulting in chin deviation and progressive facial asymmetry (Figure 4).
In the series of 49 patients included in this study, progressive facial asymmetry was observed as the main reason for consultation, and all patients showed chin deviation and asymmetry in dental occlusion.
UCH is diagnosed by clinical approach; 2D-rx is not effective for diagnosis [11] because it does not show the size and morphology of the condyle, the ramus and body of the mandible. 3D imaging, such as computed tomography (CT) or cone beam computed tomography (CBCT), shows the volumetric condition and size of the condyle, and can be used to compare the right and left condyles [12,13]; 3D imaging can be used to observe the cortical line of the condyle and to assess the bone quality as an indicator of bone metabolism.
All 49 patients presented an augmented condyle in the affected side, showing hyperplastic growth of the condylar head. Goulart et al. [12,14] reported that the bilateral hyperplastic condyle has the same size, morphology and volume as the condyle involved in UCH, demonstrating that a class III dental occlusion could be related to bilateral hyperplastic condyles, as previously proposed by Wolford [6] and Obwegeser [7].
The main use of SPECT in UCH treatment is to perform a comparison between the condyles. In 1985, Matteson [15] demonstrated the utility of 99mTc in bone scanning to assess abnormal condylar growth, and in 2007, Lippold et al. [16] determined the biological basis for using a bone scan to assess the activity level of the condyle. SPECT analysis was used for diagnosis, and no correlations were observed between age, sex, clinical type or the uptake of 99mTc and the SPECT results. Karssemakers et al. [13] investigated 20 subjects with an average age of 22.8 y. (for an age range of 10 to 39 y.o.) and did not find any correlation between the trabecular bone volume fraction and trabecular thickness of the condyle and the condylar activity on the preoperative bone scan, showing that the bone volume was not related to bone activity [17].
In histological analysis, Fariña et al. [18] found no correlation between histological conditions and SPECT results, and Saridin [19] found low consistency in the correlation used to evaluate the uptake of 99mTc and the histologic evidence. A SPECT analysis cannot be used to distinguish among inflammatory, infective or healing processes [20]. Some reports [5] show difficulties in obtaining accurate results when comparing different techniques for SPECT measurements in UCH diagnosis because the considerable variation in terms of sensitivity and specificity. SPECT measurement can be related not only to abnormal condylar growth, but to bone blood flow, vascular permeability and bone metabolism [21,22].
Lopez et al. showed that SPECT was not related to age or sex; they also showed that the specificity of the SPECT could be improved using clinical and tomographic study to quantify the mandibular deviation [23]. Age could be a significant variable in some characteristics of the active UCH. Saridin [24] showed variability in the cartilage thickness and islands in resected condyles and that age was inversely related to the thickness of the cartilage layer. Previous histological results from our group led to similar conclusions [25,26]. Nitzan et al. [27] reported a large clinical series showing a larger impact of UCH in patients under 30 years old, and Wolford’s classification was related to age in the initial stage of UCH. For that reason, SPECT must be used in the armamentarium for UCH diagnosis, with other variables as shown in this research.
UCH was present in 21 subjects between 11 and 16 y.o. (42.9%) and 28 subjects between 17 and 45 y.o. (57.1%), showing a higher incidence of the disease in the initial 6 years of adolescence than during adulthood. A low metabolism and the absence of a growth process of the condyle in the cases of older subjects could be the main reason for this difference [13].
In terms of the clinical type, type I (horizontal) was present in 45% of subjects with an average age of 16.8 y. (±3.5), type II (vertical) was present in 20% of subjects with an average age of 22.7 y. (±11.2) and type III was present in 35% of subjects with an average age of 19.9 y. (±7.8); no statistical relationship between the clinical type and the age was observed. Villanueva-Alcojol [3] recorded the clinical distribution of the facial type, showing 66.7% of patients were type I with an average age of 21.7 y. o. (±7.4), 22% of patients were type II with an average age of 25.6 y.o. (±3.2) and 11.1% of patients were type III with an average age of 26 y.o. (±7.1). Clinical type I would be common in younger patients, but no statistical relations were observed.
Between 10 and 15 years old, the condylar head can grow in a vertical position over 10 mm in females and 15 mm in male patients, which is related to facial bone growth [28] under normal and abnormal conditions. Faster movement of the facial bone is observed in younger patients because of the adolescent growth process. Usually, the neck, ramus and body of the mandible grow proportionally with the condyle, so a large condyle indicates a large mandible, and a short condyle indicates a short mandible [29,30]; this fact has been confirmed by the results in an animal model showing mandibular modification based on the use of growth factors in the condyle [31].
However, as facial growth has stopped in adults, different characteristics for the condyle are observed in adults vs. adolescents; this difference could be an argument for the differences of clinical behavior in the UCH and the SPECT variations regarding specificity and sensibility. Indeed, Shetty and Guddadararangiah [32] showed a sequence of pictures of a patient from early age to adult age, showing great differences in terms of facial morphology related to progressive facial asymmetry.
High condylectomy was used to treat the affected side in all the patients. Fourteen (28.5%) patients were submitted to a secondary surgical treatment for orthognathic or cosmetic surgery; this secondary treatment was not related to the variables included in the diagnosis.
Interestingly, in the case of second surgical treatment and after high condylectomy, this was present in 4.5% of the clinical type I, in 50% of the clinical type II and in 36.7% of the clinical type III. No statistical differences were observed; however, it is possible to assume that more complex deformities are present in the clinical type II and III and this can be the reason for more treatment requirements.
In the same line, second surgical treatment was observed in 9.5% of subjects under 16 years old and in 42.8% of the subjects between 17 and 45 years old; while there were no observed statistical differences, it could be assumed that the early treatment can help in a better resolution of the functional and esthetic concerns.
Limitations in this research are related to the observational nature of the investigation. The absence of groups to compare the variables and the results of treatment with could be a problem to define a better protocol for the diagnosis and treatment of subjects with UCH.
No independent variables included in this research show exclusive correlations with UCH diagnosis and treatment. Clinical analysis, medical records, 3D imaging and SPECT should be used as a complementary analysis to assess the diagnosis of UCH and progressive facial asymmetry.

Author Contributions

Conceptualization, J.B. and S.O.; methodology, J.B., C.Z., H.D.N. and S.O.; software, C.Z., M.P.M. and H.D.N.; validation, J.B. and M.P.M.; formal analysis, C.Z.; investigation, J.B., M.P.M., H.D.N. and S.O.; data curation, C.Z.; writing—review & editing, J.B., C.Z., M.P.M., H.D.N. and S.O. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board (UFJF-IRB, protocol 2.148.583).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data are available upon request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Olate, S.; Netto, H.D.; Rodriguez-Chessa, J.; Alister, J.P.; de Albergaria-Barbosa, J.; de Moraes, M. Mandible condylar hyperplasia: A review of diagnosis and treatment protocol. Int. J. Clin. Exp. Med. 2013, 6, 727–737. [Google Scholar] [PubMed]
  2. Nolte, J.W.; Schreurs, R.; Karssemakers, L.H.E.; Tuinzing, D.B.; Becking, A.G. Demographic features in Unilateral Condylar Hyperplasia: An overview of 309 asymmetric cases and presentation of an algorithm. J. Craniomaxillofac. Surg. 2018, 46, 1484–1492. [Google Scholar] [CrossRef]
  3. Villanueva-Alcojol, L.; Monje, F.; González-García, R. Hyperplasia of the mandibular condyle: Clinical, histopathologic, and treatment considerations in a series of 36 patients. J. Oral Maxillofac. Surg. 2011, 69, 447–455. [Google Scholar] [CrossRef]
  4. Martin-Granizo, R.; Garcia-Rielo, J.M.; De la Sen, O.; Maniegas, L.; Berguer, A.; De Pedro, M. Correlation between single photon emission computed tomography and histopathologic findings in condylar hyperplasia of the temporomandibular joint. J. Craniomaxillofac. Surg. 2017, 45, 839–844. [Google Scholar] [CrossRef] [PubMed]
  5. Chan, B.H.; Leung, Y.Y. SPECT bone scintigraphy for the assessment of condylar growth activity in mandibular asymmetry: Is it accurate? Int. J. Oral Maxillofac. Surg. 2018, 47, 470–479. [Google Scholar] [CrossRef]
  6. Obwegeser, H.L.; Makek, M.S. Hemimandibular hyperplasia—Hemimandibular elongation. J. Maxillofac. Surg. 1986, 14, 183–208. [Google Scholar] [CrossRef] [PubMed]
  7. Wolford, L.M.; Movahed, R.; Perez, D.E. A classification system for conditions causing condylar hyperplasia. J. Oral Maxillofac. Surg. 2014, 72, 567–595. [Google Scholar] [CrossRef]
  8. Maniskas, S.; Ly, C.L.; Parsaei, Y.; Bruckman, K.C.; Steinbacher, D.M. Facial asymmetry in unilateral condylar hyperplasia: Comparing treatment for active versus burnt-out disease. Plast. Reconstr. Surg. 2020, 146, 439e–445e. [Google Scholar] [CrossRef] [PubMed]
  9. Higginson, J.A.; Bartram, A.C.; Banks, R.J.; Keith, D.J.W. Condylar hyperplasia: Current thinking. Br. J. Oral Maxillofac. Surg. 2018, 56, 655–662. [Google Scholar] [CrossRef] [PubMed]
  10. Olate, S.; Almeida, A.; Alister, J.P.; Navarro, P.; Netto, H.D.; de Moraes, M. Facial asymmetry and condylar hyperplasia: Considerations for diagnosis in 27 consecutives patients. Int. J. Clin. Exp. Med. 2013, 6, 937–941. [Google Scholar] [PubMed]
  11. Zapata, S.; Medina, H.; Saravia, D.; Navarro, P.; Olate, S. Morphometric analysis of the mandible in patients with facial asymmetry associated to condylar hyperplasia. A panoramic radiography study. Int. J. Morphol. 2014, 32, 161–165. [Google Scholar] [CrossRef] [Green Version]
  12. Goulart, D.R.; Muñoz, P.; Cantín López, M.G.; de Moraes, M.; Olate, S. Comparative evaluation of condylar volume between patients with unilateral condylar hyperplasia and class III dentofacial deformity. J. Oral Maxillofac. Surg. 2017, 75, 180–188. [Google Scholar] [CrossRef] [Green Version]
  13. Karssemakers, L.H.E.; Nolte, J.W.; Tuinzing, D.B.; Langenbach, G.E.J.; Becking, A.G.; Raijmakers, P.G. Impact of bone volume upon condylar activity in patients with unilateral condylar hyperplasia. J. Oral Maxillofac. Surg. 2018, 76, 2177–2182. [Google Scholar] [CrossRef] [PubMed]
  14. Goulart, D.R.; Muñoz, P.; Olate, S.; de Moraes, M.; Fariña, R. No differences in morphological characteristics between hyperplastic condyle and class III condyle. Int. J. Oral Maxillofac. Surg. 2015, 44, 1281–1286. [Google Scholar] [CrossRef]
  15. Matteson, S.R.; Proffit, W.R.; Terry, B.C.; Staab, E.V.; Burkes, E.J., Jr. Bone scanning with 99mtechnetium phosphate to assess condylar hyperplasia. Report of two cases. Oral Surg. Oral Med. Oral Pathol. 1985, 60, 356–367. [Google Scholar] [CrossRef]
  16. Lippold, C.; Kruse-Losler, B.; Danesh, G.; Joos, U.; Meyer, U. Treatment of hemimandibular hyperplasia: The biological basis of condylectomy. Br. J. Oral Maxillofac. Surg. 2007, 45, 353–360. [Google Scholar] [CrossRef] [PubMed]
  17. Karssemakers, L.H.; Nolte, J.W.; Tuinzing, D.B.; Langenbach, G.E.; Raijmakers, P.G.; Becking, A.G. Microcomputed tomographic analysis of human condyles in unilateral condylar hyperplasia: Increased cortical porosity and trabecular bone volume fraction with reduced mineralisation. Br. J. Oral Maxillofac. Surg. 2014, 52, 940–944. [Google Scholar] [CrossRef] [PubMed]
  18. Fariña, R.A.; Becar, M.; Plaza, C.; Espinoza, I.; Franco, M.E. Correlation between single photon emission computed tomography, AgNOR count, and histomorphologic features in patients with active mandibular condylar hyperplasia. J. Oral Maxillofac. Surg. 2011, 69, 356–361. [Google Scholar] [CrossRef] [PubMed]
  19. Saridin, C.P.; Raijmakers, P.G.; Al Shamma, S.; Tuinzing, D.B.; Becking, A.G. Comparison of different analytical methods used for analyzing SPECT scans of patients with unilateral condylar hyperactivity. Int. J. Oral Maxillofac. Surg. 2009, 38, 942–946. [Google Scholar] [CrossRef]
  20. Shintaku, W.H.; Venturin, J.S.; Langlais, R.P.; Clark, G.T. Imaging modalities to access bony tumors and hyperplasic reactions of the temporomandibular joint. J. Oral Maxillofac. Surg 2010, 68, 1911–1921. [Google Scholar] [CrossRef]
  21. Liu, P.; Shi, J. Is single-photon emission computed tomography/computed tomography superior to single-photon emission computed tomography in assessing unilateral condylar hyperplasia? J. Oral Maxillofac. Surg. 2019, 77, e1–e7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. López Buitrago, D.F.; Muñoz Acosta, J.M.; Cárdenas-Perilla, R.A. Comparison of four methods for quantitative assessment of 99mTc-MDP SPECT in patients with suspected condylar hyperplasia. Rev. Esp. Med. Nucl. Imagen. Mol. 2019, 38, 72–79. [Google Scholar] [CrossRef] [PubMed]
  23. López, D.F.; Ríos Borrás, V.; Muñoz, J.M.; Cardenas-Perilla, R.; Almeida, L.E. SPECT/CT Correlation in the diagnosis of unilateral condilar hyperplasia. Diagnostics 2021, 11, 477. [Google Scholar] [CrossRef]
  24. Saridin, C.P.; Raijmakers, P.G.; Slootweg, P.J.; Tuinzing, D.B.; Becking, A.G.; van der Waal, I. Unilateral condylar hyperactivity: A histopathologic analysis of 47 patients. J. Oral Maxillofac. Surg. 2010, 68, 47–53. [Google Scholar] [CrossRef] [PubMed]
  25. Vásquez, B.; Olate, S.; Cantín, M.; Sandoval, C.; Del Sol, M.; de Moraes, M. Histomorphometric analysis of unilateral condylar hyperplasia in the temporomandibular joint: The value of the condylar layer and cartilage island. Int. J. Oral Maxillofac. Surg. 2017, 46, 861–866. [Google Scholar] [CrossRef]
  26. Vásquez, B.; Olate, S.; Cantín, M.; Sandoval, C.; Fariña, R.; Del Sol, M. Histopathological analysis of unilateral condylar hyperplasia: Difficulties in diagnosis and characterization of the disease. Int. J. Oral Maxillofac. Surg. 2016, 45, 601–609. [Google Scholar] [CrossRef]
  27. Nitzan, D.W.; Katsnelson, A.; Bermanis, I.; Brin, I.; Casap, N. The clinical characteristics of condylar hyperplasia: Experience with 61 patients. J. Oral Maxillofac. Surg. 2008, 66, 312–318. [Google Scholar] [CrossRef]
  28. Buschang, P.H.; Gandini Júnior, L.G. Mandibular skeletal growth and modelling between 10 and 15 years of age. Eur. J. Orthod. 2002, 24, 69–79. [Google Scholar] [CrossRef] [Green Version]
  29. Olate, S.; Cantín, M.; Alister, J.P.; Uribe, F.; Navarro, P.; Olate, G.; de Moraes, M. Relación entre el tamaño condilar y la asimetría facial transversal en individuos con hiperplasia condilar [Relationship between condylar size and transverse facial asymmetry in subject with condylar hyperplasia]. Int. J. Morphol. 2013, 31, 937–941. [Google Scholar] [CrossRef] [Green Version]
  30. Muñoz, G.; Olate, S.; Cantín, M.; Vásquez, B.; Del Sol, M. TMJ in facial class III deformity. Condylar morphology relations. Int. J. Clin. Exp. Med. 2014, 15, 3113–3117. [Google Scholar]
  31. Rabie, A.B.; Dai, J.; Xu, R. Recombinant AAV-mediated VEGF gene therapy induces mandibular condylar growth. Gene Ther. 2007, 14, 972–980. [Google Scholar] [CrossRef] [PubMed]
  32. Shetty, S.; Guddadararangiah, S. Case report: Unilateral condylar hyperplasia. F1000Research 2021, 10, 46. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Clinical presentation of unilateral condylar hyperplasia and facial asymmetry. (A) chin deviation with a class III trend; (B) lack in dental midline and unilateral crossbite dental occlusion.
Figure 1. Clinical presentation of unilateral condylar hyperplasia and facial asymmetry. (A) chin deviation with a class III trend; (B) lack in dental midline and unilateral crossbite dental occlusion.
Jcm 12 01017 g001
Figure 2. Classification of the facial asymmetry related to unilateral condylar hyperplasia. (A) type 1, with a horizontal component with UCH on the right side; (B) type 2, with a vertical component with UCH on the left side; (C) type 3, with a horizontal and vertical component and UCH on the left side.
Figure 2. Classification of the facial asymmetry related to unilateral condylar hyperplasia. (A) type 1, with a horizontal component with UCH on the right side; (B) type 2, with a vertical component with UCH on the left side; (C) type 3, with a horizontal and vertical component and UCH on the left side.
Jcm 12 01017 g002
Figure 3. Hyperplastic growth of the condyle on the left side in different subjects showing progressive facial asymmetry. (A) Young subject with an augmented condyle on the left side (note the augmented articular space in the right TMJ with a normal size of the condyle). (B) Augmented condyle on the left side with more differences in height and width compared to the right condyle in an older subject.
Figure 3. Hyperplastic growth of the condyle on the left side in different subjects showing progressive facial asymmetry. (A) Young subject with an augmented condyle on the left side (note the augmented articular space in the right TMJ with a normal size of the condyle). (B) Augmented condyle on the left side with more differences in height and width compared to the right condyle in an older subject.
Jcm 12 01017 g003
Figure 4. CBCT of the same subject in sagittal view. (A) left condyle in normal growth and (B) right condyle with hyperplastic growth involving neck and ramus of the same side of the mandible. The progressive asymmetry will move all the sides involved in the abnormal growth of the condyle.
Figure 4. CBCT of the same subject in sagittal view. (A) left condyle in normal growth and (B) right condyle with hyperplastic growth involving neck and ramus of the same side of the mandible. The progressive asymmetry will move all the sides involved in the abnormal growth of the condyle.
Jcm 12 01017 g004
Table 1. Variables and criteria related to diagnosis in unilateral condylar hyperplasia applied to this research.
Table 1. Variables and criteria related to diagnosis in unilateral condylar hyperplasia applied to this research.
TestCharacteristics and Definition
Family medical recordFamily or patient describes a progressive facial asymmetry, occurring in the last time
With or without any family with facial deformity or facial asymmetry
Pain or noise in the affected condyle could be reported
Facial analysisChin midline deviation with the facial midline
Asymmetry in mandibular angles (vertical or horizontal differences)
Dental conditionsCan be present with unilateral crossbite in the canine and/or molar area or unilateral open bite mainly in the posterior area
Progressive deviation of the dental midline with more than 4 mm.
Trend to class III dental occlusion
CBCTAugmentation in condylar size in comparison to the non-hyperplastic condyle
Lack in upper cortical line of the affected condyle in the upper area showing an active metabolism
Augmentation in radiolucency in the affected condyle with an image related to poor density in some cases
SPECTDifferences 10% in caption of the radioisotope between the hyperplastic and the non-hyperplastic condyle
Table 2. Distribution of subjects with UCH according to clinical type I.
Table 2. Distribution of subjects with UCH according to clinical type I.
SexAgeAffected SideSPECT DifferencesSecondary Surgery
F17R12NO
F19L6YES
F14L10NO
F22L16NO
F17L10NO
M22L14NO
F22R10NO
F14L18NO
F22L6NO
F12R48NO
F15R10NO
F14L14NO
F17L22NO
F14L10NO
F17L14NO
F22R18NO
M15R12NO
F10L12NO
M16L26NO
F18R24NO
F13R18NO
M18R16NO
Average16.81 15.72
Standard Deviation3.55 8.92
F: Female; M: Male; R: Right; L: Left.
Table 3. Distribution of subjects with UCH according to clinical type II.
Table 3. Distribution of subjects with UCH according to clinical type II.
SexAgeAffected SideSPECT DifferencesSecondary Surgery
F15R16NO
F23R18YES
F21L16YES
F13L22NO
F45L28YES
F14L26NO
F41L10YES
F16L26YES
F20R24NO
M19L20NO
Average22.7 20.6
Standard Deviation11.2 5.66
F: Female; M: Male; R: Right; L: Left.
Table 4. Distribution of subjects with UCH according to clinical type III.
Table 4. Distribution of subjects with UCH according to clinical type III.
SexAgeAffected SideSPECT DifferencesSecondary Surgery
F18L10YES
F14L16NO
F21L10NO
F16R20YES
F22L16YES
F14L22NO
F22R23YES
F18R24YES
F35R10YES
F14R26NO
F16R40NO
F17R14YES
F14R12NO
F16R12NO
F17R16NO
M22L28NO
M43L22YES
Average19.94 18.88
Standard Deviation7.84 7.99
F: Female; M: Male; R: Right; L: Left.
Table 5. Distribution of subjects with UCH between 10 and 16 years old.
Table 5. Distribution of subjects with UCH between 10 and 16 years old.
SexAgeAffected SideSPECT (R/L)SPECT DifferencesClinical TypeSecondary Surgery
F10L44/56121NO
F12R74/26481NO
F13L39/61222NO
F13R59/41181NO
F14L42/58163NO
F14L45/55101NO
F14L41/59181NO
M14L39/61223NO
F14L43/57141NO
F14L37/63262NO
F14L45/55101NO
F14R63/37263NO
F14R56/44123NO
F15R58/42162NO
F15R55/45101NO
M15R56/44121NO
F16R60/40203YES
F16R30/70403NO
F16L37/63262YES
M16L37/63261NO
F16R56/44123NO
Average14.23 19.8
Standard Deviation1.48 9.9
F: Female; M: Male; R: Right; L: Left.
Table 6. Distribution of variables of subjects with UCH between 17 and 45 years old.
Table 6. Distribution of variables of subjects with UCH between 17 and 45 years old.
SexAgeAffected SideSPECT (R/L)SPECT DifferencesClinical TypeSecondary Surgery
F17R56/44121NO
F17L55/45101NO
F17L39/61221NO
F17R57/43143YES
F17L43/57141NO
F17R58/42163NO
F18L45/55103YES
F18R62/38243YES
F18R62/38241NO
M18R58/42161NO
F19L47/5361YES
M19L40/60202NO
F20R62/38242NO
F21L45/55103NO
F21L58/42162YES
F22L42/58161NO
M22L43/57141NO
F22R55/45101NO
F22L42/58163YES
F22L47/5361NO
F22R61/39233YES
F22R59/41181NO
M22L36/64283NO
F23R59/41182YES
F35R55/45103YES
F41L45/55102YES
M43L39/61223YES
F45L36/64282YES
Average22.75 16.32
Standard Deviation7.98 6.28
F: Female; M: Male; R: Right; L: Left.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Beltran, J.; Zaror, C.; Moya, M.P.; Netto, H.D.; Olate, S. Diagnosis and Treatment in Unilateral Condylar Hyperplasia. J. Clin. Med. 2023, 12, 1017. https://doi.org/10.3390/jcm12031017

AMA Style

Beltran J, Zaror C, Moya MP, Netto HD, Olate S. Diagnosis and Treatment in Unilateral Condylar Hyperplasia. Journal of Clinical Medicine. 2023; 12(3):1017. https://doi.org/10.3390/jcm12031017

Chicago/Turabian Style

Beltran, Jorge, Carlos Zaror, María Paz Moya, Henrique Duque Netto, and Sergio Olate. 2023. "Diagnosis and Treatment in Unilateral Condylar Hyperplasia" Journal of Clinical Medicine 12, no. 3: 1017. https://doi.org/10.3390/jcm12031017

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop